Pharmaceutical

FDA cracks down on online retailers selling unapproved GLP-1 agonists

The FDA has issued warning letters to two online sellers for selling unapproved versions of semaglutide and tirzepatide.

Feb 14, 2024 - 18:00
FDA cracks down on online retailers selling unapproved GLP-1 agonists
The FDA has issued warning letters to two online sellers for selling unapproved versions of semaglutide and tirzepatide.
Read the original article

Tags:

Previous Article

SCOPE: Changing protocol language and site actions are key to making trials incl...

Next Article

BMS signs $674m GenAI drug discovery deal with VantAI

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: STAT+: The PATCH Act’s approach to securing medical devices actually gives malicious actors a blueprint

Opinion: STAT+: The PATCH Act’s approach to securing me...

Nov 7, 2023

How a conservative, gun-toting doctor defended abortion access in Appalachia

How a conservative, gun-toting doctor defended abortion...

Sep 6, 2023

Oscotec sees highest patent filings and grants during June in Q2 2024

Oscotec sees highest patent filings and grants during J...

Jul 22, 2024